Clinical Trial Update: A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients [Phase 3]

View source ↗

Summary

Phase 3 confirmatory trial of Hepabulin IV in HBsAg-positive liver transplant recipients has completed; this update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepabulin IV

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED